Hill C, Doyon F
Institut Gustave-Roussy, 94805 Villejuif Cedex.
Bull Cancer. 2001 Oct;88(10):1019-22.
To measure the frequency of cancer in a given country on a given year, one can use the number of new diagnosis or the number of deaths, but one can also consider the number of patients who have had a cancer diagnosed in the past and are still alive. This indicator is called prevalence. We present here estimations for the prevalence of cancer at 5 years in France, by sex and by site of cancer. These estimations are based on the number of new diagnoses in 1995 and on survival rates observed in Europe. In year 2000, 620,000 persons (310,000 men and 310,000 women) were followed up in France for a cancer diagnosed within the last 5 years. The most prevalent cancers were breast (136,000 cases), colorectal (91,000 cases) and prostate (83,000 cases) cancers.
为了衡量某一特定国家在某一年的癌症发病率,人们可以使用新诊断病例数或死亡人数,但也可以考虑过去已被诊断出癌症且仍存活的患者人数。这个指标被称为患病率。我们在此展示了法国按性别和癌症部位划分的5年癌症患病率估计值。这些估计值基于1995年的新诊断病例数以及在欧洲观察到的生存率。2000年,法国对过去5年内被诊断出癌症的62万人(31万男性和31万女性)进行了随访。最常见的癌症是乳腺癌(13.6万例)、结直肠癌(9.1万例)和前列腺癌(8.3万例)。